Pomerantz Law Firm Investigates Omeros Corporation for Potential Securities Fraud
The Pomerantz Law Firm is investigating potential securities fraud or other unlawful business practices by Omeros Corporation and its officers. The investigation follows a negative opinion from the EMA's CHMP on narsoplimab, causing Omeros' stock to drop nearly 19%.
Tickers: $OMER
Topics: investor_relations legal stock_price_drop